Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
November 3, 2022
Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101
November 3, 2022
State of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction Crisis
October 27, 2022
Homology Medicines Presents on Design of pheEDIT Trial Evaluating One-Time Nuclease-Free Gene Editing Candidate HMI-103 for PKU at American Society of Human Genetics Meeting
October 27, 2022
Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
October 25, 2022
TMRW Life Sciences Launches World’s Most Advanced Specimen Management Facility for Frozen Eggs and Embryos Used In IVF
October 21, 2022
CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research
October 19, 2022
Anna Yaeger Joins 5AM Ventures as Partner, Head of Public Equities
October 18, 2022
Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
October 18, 2022
Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2022
October 18, 2022
IDEAYA Announces Phase 2 MAT2A Inhibitor, IDE397, Achieves First-Patient-In for Multiple Combination Cohorts in MTAP-Deletion Tumors
« Previous Page
1
…
3
4
5
6
7
…
103